Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b.
Saved in:
| Title: | Neutrophil-to-lymphocyte ratio half reduction as a surrogate of molecular response in polycythemia vera treated with ropeginterferon alfa-2b. |
|---|---|
| Authors: | Yoon SY; Division of Hematology and Medical Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea., Yoon SS; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Yang DH; Department of Internal Medicine, Chonnam National University Hwasun Hospital, Chonnam National University Medical School, Hwasun, Jeollanam-do, Korea., Lee GW; Division of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea., Sohn SK; Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea., Shin HJ; Department of Hematology/Oncology, Pusan National University Hospital, Busan, Korea., Bae SH; Division of Hematology/Oncology, Department of Internal Medicine, Daegu Catholic, University Hospital, Daegu Catholic University School of Medicine, Daegu, Korea., Choi CW; Division of Oncology and Hematology, Department of Internal Medicine, Korea University Medical Center, Seoul, Korea., Choi EJ; Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea., Cheong JW; Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea., Bang SM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea., Park JS; Departments of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea., Park Y; Division of Hematology-Oncology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea., Park YH; Division of Hematology-Oncology, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Seoul, Korea., Lee SE; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 06591, Korea. |
| Source: | Therapeutic advances in hematology [Ther Adv Hematol] 2026 Mar 30; Vol. 17, pp. 20406207261431904. Date of Electronic Publication: 2026 Mar 30 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2040-6207 |
|---|---|
| DOI: | 10.1177/20406207261431904 |
